Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-015026
Filing Date
2024-02-16
Accepted
2024-02-16 19:37:06
Documents
2
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 26361
2 POWER OF ATTORNEY ea193950ex24_cerotherap.htm EX-24 7178
  Complete submission text file 0001213900-24-015026.txt   35115
Mailing Address 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40877 | Film No.: 24650182

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)